Dr. Anthony Boutin, MD

Dr. Boutin practices at Nassau University Medical Center in East Meadow, New York, part of NuHealth.

Dr. Boutin's NPI, 1386681120, was assigned on June 1, 2006. Dr. Boutin graduated from New York Medical College in 1991. Dr. Boutin holds New York license 195825.

Dr. Boutin's primary practice is Nassau University Medical Center, at 2201 Hempstead Turnpike, East Meadow, NY 11554 in Nassau County. The practice phone is (516) 572-0123.

Dr. Boutin's primary practice is Nassau University Medical Center in East Meadow, New York, part of NuHealth. Dr. Boutin is also affiliated with NYC Health + Hospitals/Elmhurst. The medical group on file is Nassau University Medical Center (NUMC), Department of Psychiatry and Behavioral Sciences. Dmand AI also links Dr. Boutin to 4 more hospitals and 5 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boutin practices, 6 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Dr. Boutin's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Dr. Boutin is licensed in New York.

CMS data shows 162 Medicare services from Dr. Boutin across 4 procedure codes in 2024, for 146 Medicare patients. Medicare paid $12,203 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 146 Medicare patients who saw Dr. Boutin in 2024. The largest group is 75 to 84, with 50 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 45% are also on Medicaid. Their average risk score is 1.78, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Boutin's median patient age at 47, with 53% women.

In 2024, Dr. Boutin wrote 129 Medicare Part D claims for 94 patients. 94% of them were for generic drugs. CMS names the drug for 52 of them, across 3 drugs with 11 or more claims each, at $244 in total drug cost. In 2018, CMS named 19 claims across 1 drug.

Dr. Boutin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Boutin, published from 2016 to 2017. 2016 was the busiest year, with 2. The most frequent topics are Trauma Centers. Dr. Boutin's most frequent co-author is Marianne Frieri, MD.

CMS Open Payments shows 7 general payments to Dr. Boutin from 3 drug and device companies from 2016 to 2018. Food and beverage make up the largest share, 100% of the total. Boehringer Ingelheim Pharmaceuticals, Inc. paid the most, $339.

Dr. Boutin graduated from New York Medical College in 1991.